1. Home
  2. SIMO vs MIRM Comparison

SIMO vs MIRM Comparison

Compare SIMO & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Silicon Motion Technology Corporation

SIMO

Silicon Motion Technology Corporation

HOLD

Current Price

$90.34

Market Cap

3.2B

Sector

Technology

ML Signal

HOLD

Logo Mirum Pharmaceuticals Inc.

MIRM

Mirum Pharmaceuticals Inc.

HOLD

Current Price

$78.82

Market Cap

4.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SIMO
MIRM
Founded
1995
2018
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
4.2B
IPO Year
2005
2019

Fundamental Metrics

Financial Performance
Metric
SIMO
MIRM
Price
$90.34
$78.82
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
11
Target Price
$103.13
$92.45
AVG Volume (30 Days)
266.7K
813.7K
Earning Date
02-04-2026
11-04-2025
Dividend Yield
2.22%
N/A
EPS Growth
8.75
N/A
EPS
2.87
N/A
Revenue
$798,326,000.00
$471,794,000.00
Revenue This Year
$10.15
$53.78
Revenue Next Year
$17.72
$19.91
P/E Ratio
$31.44
N/A
Revenue Growth
N/A
53.66
52 Week Low
$37.21
$36.88
52 Week High
$106.60
$82.58

Technical Indicators

Market Signals
Indicator
SIMO
MIRM
Relative Strength Index (RSI) 53.00 62.89
Support Level $87.98 $63.23
Resistance Level $91.19 $82.58
Average True Range (ATR) 3.03 3.74
MACD 0.19 1.62
Stochastic Oscillator 54.21 81.03

Price Performance

Historical Comparison
SIMO
MIRM

About SIMO Silicon Motion Technology Corporation

Silicon Motion Technology Corp is engaged in developing NAND flash controllers for SSDs and other solid state storage devices. Its only operating segment is to develop NAND flash controllers and SSDs solutions. The company derives revenue from product categories such as Mobile Storage, Mobile Communications, and others. Silicon's geographical segments are Taiwan, the United States, Korea, China, Singapore, Malaysia, and others. The company products are used in Personal Computing, Smartphone/Tablet/CE, Flash Card/USB Flash Drive, Industrial and Embedded, Automotive, and Enterprise and Data centers.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks: